Specifically, GLP-1 activity has been observed in areas like 8: The hypothalamus, which regulates appetite The brainstem, which connects gut signals to the brain The limbic system, including the nucleus accumbens and ventral tegmental area, which are involved in reward and cravings Through these pathways, GLP-1 medications may: Reduce food cravings and food noise Change how rewarding certain foods feel Lower motivation to seek out highly palatable foods There is also emerging interest in whether these effects extend beyond food
The drug has also recently been approved by the US Food and Drug Administration (FDA) under the name Zepbound for chronic weight management
Blood sugar changes When you stop taking semaglutide, your blood sugar levels will likely go back up, especially if you have diabetes
GLP-1 medications like semaglutide are approved to help certain people lose weight and improve blood sugar control, unlike stimulants such as phentermine
Meu najee spominjanim temama su lokalne reakcije na mjestu primjene, kao i razliita individualna opaanja povezana s cjelokupnim korisnikim iskustvom
